Elliott Levy

Elliott Levy, MD, currently serves as an Independent Director at Kinaset Therapeutics, Editas Medicine, Omega Therapeutics, and NuCana plc, and as a Scientific Advisor at Shasqi. Additionally, Elliott holds the position of Strategic Advisor at LianBio and Venture Partner at 5AM Ventures. Since June 2021, Elliott has been a Senior Advisor at Boston Consulting Group (BCG). Previously, from September 2014 to May 2021, Elliott was the Senior Vice President of R&D Strategy and Operations and Senior Vice President of Global Development at Amgen. Elliott also contributed as a Board Member and Board Chair for TransCelerate BioPharma, Inc. Elliott received an M.D. from Yale School of Medicine, graduating in 1987.